Sodium dehydroacetate confers broad antibiotic tolerance by remodeling bacterial metabolism

J Hazard Mater. 2022 Jun 15:432:128645. doi: 10.1016/j.jhazmat.2022.128645. Epub 2022 Mar 9.

Abstract

Antibiotic tolerance has been a growing crisis that is seriously threatening global public health. However, little is known about the exogenous factors capable of triggering the development of antibiotic tolerance, particularly in vivo. Here we uncovered that an previously approved food additive termed sodium dehydroacetate (DHA-S) supplementation remarkably impaired the activity of bactericidal antibiotics against various bacterial pathogens. Mechanistic studies indicated that DHA-S induced glyoxylate shunt and reduced bacterial cellular respiration by inhibiting the enzymatic activity of α-ketoglutarate dehydrogenase (α-KGDH). Furthermore, DHA-S mitigated oxidative stress imposed by bactericidal antibiotics and enhanced the function of multidrug efflux pumps. These actions worked together to induce bacterial tolerance to antibiotic killing. Interestingly, the addition of five exogenous amino acids, particularly cysteine and proline, effectively reversed antibiotic tolerance elicited by DHA-S both in vitro and in mouse models of infection. Taken together, these findings advance our understanding of the potential risks of DHA-S in the treatment of bacterial infections, and shed new insights into the relationships between antibiotic tolerance and bacterial metabolism.

Keywords: Antibiotic killing; Antibiotic tolerance; Bacteria; DHA-S; Metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / toxicity
  • Bacteria
  • Mice
  • Microbial Sensitivity Tests
  • Pyrones* / pharmacology

Substances

  • Anti-Bacterial Agents
  • Pyrones
  • dehydroacetic acid